Solifenacin for overactive bladder: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Solifenacin for overactive bladder: a systematic review and meta-analysis.

Solifenacin for overactive bladder: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37981898

about

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin.Cardiovascular effects of antimuscarinic agents in overactive bladder.Urinary incontinence in men: current and developing therapy options.Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.Solifenacin linked QT interval prolongation and torsades de pointes.Patient-reported outcome of solifenacin treatment among women experiencing urinary urgency and urgency incontinence.Effectiveness of Solifenacin for Managing of Bladder Spasms in Patients With Urethroplasty.Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK.

P2860

Q33560320-232FA254-99AB-49CD-937C-99B27F4D723B Q38116972-47D4E733-0C67-4920-9853-325F8291A3E2 Q38708104-43B0EBFA-5FFD-4D6E-9F56-1EB19D9681C9 Q39020998-94F4046B-C29F-4268-8E90-0C56C5F2BC3D Q41473301-69C25D53-A6EC-4154-B779-5187005FC3A3 Q44896234-F2E05AC0-E0A7-460C-820B-FCD3E86C06DB Q47152244-3486650D-2145-414C-9646-7C1608B8C256 Q48300325-F75CE254-8775-403B-90E9-5645BA1F4E0A Q54962623-79FE5D1D-8296-4D12-8E3C-5BBF630AF0C5

P2860

Solifenacin for overactive bladder: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37981898

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@en

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@nl

type

label

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@en

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@nl

prefLabel

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@en

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@nl

P1433

Q37981898-0B2DA66D-811E-4097-ABFA-D95134755E6A

P1476

Q37981898-2722CE75-5157-4E38-882B-19720BE753E5

P2093

Q37981898-23A87F34-BAA1-4737-ACA9-0440727ED5E1

Q37981898-385F77AF-6FC3-4546-B611-1DEEC61C96FC

Q37981898-4949BD6C-9F9B-488E-B999-287545D60ECD

Q37981898-5FC118D9-7F9F-4F10-99AD-6E8AFFB24783

Q37981898-AF5A5808-CED1-4A8A-BA53-3DD9A13EE0D0

P2860

Q37981898-04EF055B-5232-4632-93D5-E2C3FDD72615

Q37981898-072393CE-2AC9-4FD7-B37C-7B81F65251E7

Q37981898-0DEFA105-8D89-4068-A48C-99166B6098D0

Q37981898-1E5834FF-F1D7-483D-8ECC-6D50C85AD94E

Q37981898-1FEC0DDC-FDC1-4233-963F-553D60794642

Q37981898-2333354D-8E68-4DCD-945E-13CA21F77D94

Q37981898-2401DB2A-2522-4D81-B451-5B8225499AC7

Q37981898-2B24A498-830C-4099-9344-59A250B097B7

Q37981898-35D0126E-68B5-4287-93E5-B0374EE2293A

Q37981898-4844B91D-B117-47D8-A68C-2B313814E682

P2888

Q37981898-B2221817-D0B3-46BD-BA2B-15C6BEF58EA5

P304

Q37981898-FFA10781-E08F-4C1B-AF83-10480F0511F9

P31

Q37981898-42774DC0-B882-4B28-B480-C6940F8212FD

Q37981898-fd6dfd68-8603-4899-8abc-66d33e040f31

P356

Q37981898-62DB8970-9F4A-400B-8F09-51069CB40A2F

P433

Q37981898-517DFCD9-01FD-423E-8CC3-78933ECA90C3

P478

Q37981898-9FC1EBBD-8B32-4A07-B7B5-95F981BAB5CA

P577

Q37981898-B26965CB-FFBD-4CA7-BB28-8BF183EF33CF

P698

Q37981898-DAB55D32-9CF0-43BB-97A9-C9F326ED0A9B

P356

S00192-011-1641-7

P1433

International Urogynecology Journal and Pelvic Floor Dysfunction

P1476

Solifenacin for overactive bladder: a systematic review and meta-analysis.

@en

P2093

Deyi Luo

http://www.w3.org/2001/XMLSchema#string

Hong Shen

http://www.w3.org/2001/XMLSchema#string

Liangren Liu

http://www.w3.org/2001/XMLSchema#string

Ping Han

http://www.w3.org/2001/XMLSchema#string

Qiang Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.

Muscarinic receptor antagonists in the treatment of overactive bladder.

Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.

Muscarinic receptor antagonists for overactive bladder.

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Role of muscarinic receptor antagonists in urgency and nocturia.

Pharmacologic management of overactive bladder: practical options for the primary care physician.

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.

P2888

s00192-011-1641-7

P304

983-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00192-011-1641-7

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22310924

http://www.w3.org/2001/XMLSchema#string